Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,086 | -3,528 | -13,421 | -10,229 | -6,540 |
| Depreciation Amortization | 122 | 62 | 272 | 207 | 141 |
| Accounts payable and accrued liabilities | 490 | -267 | -987 | -1,141 | -803 |
| Other Working Capital | -459 | -838 | -2,192 | -1,620 | -1,792 |
| Other Operating Activity | -273 | 347 | -951 | -1,206 | -1,393 |
| Operating Cash Flow | $-7,206 | $-4,224 | $-17,279 | $-13,989 | $-10,387 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -7 | N/A | N/A |
| Investing Cash Flow | $N/A | $N/A | $-7 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 29,088 | 6,422 | 400 |
| Financing Cash Flow | $N/A | $N/A | $29,088 | $6,422 | $400 |
| Beginning Cash Position | 28,918 | 28,918 | 17,116 | 17,116 | 17,116 |
| End Cash Position | 21,712 | 24,694 | 28,918 | 9,549 | 7,129 |
| Net Cash Flow | $-7,206 | $-4,224 | $11,802 | $-7,567 | $-9,987 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,206 | -4,224 | -17,279 | -13,989 | -10,387 |
| Capital Expenditure | N/A | N/A | -7 | N/A | N/A |
| Free Cash Flow | -7,206 | -4,224 | -17,286 | -13,989 | -10,387 |